R&D

News

Abingworth 'will launch $1.5bn fund for co-developed drugs'

Abingworth is reported to be raising $1.5bn for further risk-sharing, royalty-bearing development deals with large pharma groups.

News

Official opening of Co.Lab Berlin site, ribbon cutting

Bayer opens Berlin incubator and welcomes first resident

Bayer's network of Co.Lab life sciences incubators has expanded once again with the official opening of a site in Berlin, its first in Europe

News

Novartis raises mid-term sales outlook on pipeline promise

Novartis has raised its guidance for sales growth out to 2029 on the strength of its pipeline and the potential of late-stage R&D assets

News

Pfizer elevates Chris Boshoff to top R&D role

Pfizer has named chief oncology officer Dr Chris Boshoff to the new role of chief of R&D

News

Chasing $80bn sales target, AZ unveils $3.5bn US investment

AstraZeneca plans to invest a whopping $3.5 billion to expand its R&D and manufacturing operations in the US by 2026, as part of a drive to raise its revenues to $80 billion by the end

News

Novo sheds kidney drug licensed for $1.3bn a year ago

Novo Nordisk has abandoned a drug it licensed from KBP Biosciences last year in a deal valued at up to $1.3 billion after it missed the mark in a chronic kidney disease (CKD) trial.

Abingworth 'will launch $1.5bn fund for co-developed drugs'

Bayer opens Berlin incubator and welcomes first resident

Novartis raises mid-term sales outlook on pipeline promise

Pfizer elevates Chris Boshoff to top R&D role

Chasing $80bn sales target, AZ unveils $3.5bn US investment

Novo sheds kidney drug licensed for $1.3bn a year ago

Infex chases after Insmed with bronchiectasis trial win

Discover a new era of healthcare panel engagement: Grounded ...

R&D

Editor's Picks